Prosecution Insights
Last updated: July 17, 2026
Application No. 18/118,228

MEDICAL VISUALIZATION AND/OR ILLUMINATION SYSTEM AND METHOD FOR INDICATING NON-VISIBLE ILLUMINATION LIGHT

Non-Final OA §103
Filed
Mar 07, 2023
Priority
Mar 16, 2022 — DE 102022106156.6
Examiner
GHIMIRE, SHANKAR RAJ
Art Unit
3795
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Schölly Fiberoptic GmbH
OA Round
3 (Non-Final)
76%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 76% — above average
76%
Career Allowance Rate
217 granted / 284 resolved
+6.4% vs TC avg
Strong +19% interview lift
Without
With
+18.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
42 currently pending
Career history
328
Total Applications
across all art units

Statute-Specific Performance

§103
80.6%
+40.6% vs TC avg
§102
9.4%
-30.6% vs TC avg
§112
6.6%
-33.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 284 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 05/20/2026 has been entered. Response to Amendment Claims 1-2, 4-12, 14-16, 18-21, 23-24, 25, are pending. Claims 3, 13, 17, 22 are cancelled. Claims 16, 18-21, 23-24 are withdrawn. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1-2, 4-8, 10-12, 14-15, 19-21, is/are rejected under 35 U.S.C. 103 as being unpatentable over Steiner (US 20200337525) in view of Bruemmer (US 20130094181). Regarding claim 1, Steiner discloses a system (FIGS. 1, 4 annotated below) configured for illuminating an object to be observed during a medical intervention with non-visible illumination light in a first wavelength range (near-infrared light for fluorescent generation), the system comprising: a converter (fluorescent indicator 102) which converts at least some of the non-visible illumination light into an optical indication signal in the form of visible indication light that is perceivable by humans (Fluorescent indicator 102 is back-lit by the excitation light 12a, from, for example, a fiber optic channel, when the user enters the fluorescence imaging mode of the system; Para [0020]; The fluorescent indicator may be indocyanine green; para [0003]); and an endoscope (FIG. 1; an endoscope for imaging a fluorescent agent in a patient; para [0003]), wherein the non-visible illumination light is emitted from a distal end region (near-infrared light for fluorescent generation; FIG. 1) of the endoscope and the indication signal is emitted: through a window (Fluorescent indicator 102 is positioned at the proximal side and is inside a window 102; FIGS. 2A-2D; The fluorescent indicator may be indocyanine green; para [0003]; FIG. 2B annotated below.) in a direction perpendicular to a direction in which the non-visible illumination light is emitted from the distal end region (The direction of travel of the non-visible illumination light is not defined. The non-visible illumination light that comes out in the distal end in a radial direction can be referenced as the direction of the non-visible illumination light and the signal from window 102 can be perpendicular to that non-visible illumination light.); wherein the converter comprises a conversion material (The fluorescent indicator may be indocyanine green; para [0003]), and wherein at least one of: the visible indication light is observable through the window from outside the sealed interior space (FIGS. 2A-2D). PNG media_image1.png 546 983 media_image1.png Greyscale Steiner is silent regarding wherein the window is sealed into a housing of the system so as to form a sealed interior space the converter is arranged in the sealed interior space. Bruemmer is directed to a phosphor device (abstract) and teaches wherein the window is sealed into a housing of the system so as to form a sealed interior space; and the converter is arranged in the sealed interior space (Phosphor is safe from corrosive environments or humidity if sealed in a proper manner. FIG. 3; carrier member 1 made of aluminum seals phosphor layer 3; Para [0019], [0029]). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Steiner to include a sealed housing in accordance with the teaching of Bruemmer so that the converter remains sealed in the housing and remains safe from the environment (Para [0019] of Bruemmer). Regarding claim 2, Steiner discloses wherein the converter outputs the indication signal only if the non-visible illumination light is present (The fluorescent indicator may be indocyanine green and the first light source may have an excitation wavelength in the near infrared. Para [0003]). Regarding claim 4, Steiner discloses wherein the converter is configured to convert the at least some of the illumination light into the visible indication light based on a photoactive substance (The fluorescent indicator may be indocyanine green; para [0003]) which enables optical wavelength conversion of the illumination light into the indication light without an external energy supply. Regarding claim 5, Steiner discloses wherein the converter comprises a photoactive conversion material (The fluorescent indicator may be indocyanine green which requires a photoactive conversion material; para [0003), and the conversion material is applied as a conversion layer on a carrier body (FIGS. 1, 2A-2D). Regarding claim 6, Steiner discloses wherein the conversion material contains a photoactive substance applied on a ceramic as the carrier body (Note the carrier body in FIG. 1; Also see, FIGS. 2A-2D). Regarding claim 7, Steiner discloses wherein the illumination light is at least one of reflected or transmitted by the converter (The illumination light is transmitted via the indicator 102; FIGS. 1, 2A-2D). Regarding claim 8, Steiner discloses wherein the converter, upon the conversion of the non-visible illumination light into the visible indication light, is configured to effect conversion from longer wavelengths to shorter wavelengths (Infrared light is transformed to indocyanine green. Para [0003]). Regarding claim 10, Steiner as modified, discloses wherein: the converter is arranged in the sealed interior space (Bruemmer: Phosphor layer 3 is sealed in member 1 made of aluminum; para [0019], [0029]) and the visible indication light is observable through the window from outside the sealed interior space (Steiner: FIGS. 2A-2D). Regarding claim 11, Steiner discloses wherein the converter is arranged in a housing (FIG. 1) that surrounds a light guide (Note the light guide in FIG. 1), which propagates the invisible illumination light to an illumination optical unit. Regarding claim 12, Steiner discloses wherein the converter is arranged such that the converter is located extracorporeally (FIG. 1) when the visualization and/or illumination system is used. Regarding claim 14, Steiner discloses an internal light guide (FIG. 1) forming a branch which branches off some of the illumination light from an optical main path used for the illumination and the branch guides some of the illumination light to the converter (Light guide is branched off; FIG. 1). Regarding claim 15, Steiner discloses wherein the system comprises an endoscope (FIG.1), an exoscope, a microscope or an illumination optical unit. Regarding claim 19, Steiner discloses a light source configured to emit the illumination light (Visible light source 13) and arranged in an interior space (FIG. 1), and a light guide arranged in the interior space (FIG.1) and configured to guide the illumination light to the converter (Indicator 102; FIG. 1). Regarding claim 20, Steiner discloses wherein the light source is arranged in a distal end region of the endoscope (Visible light source 13 is propagated to the distal end and exit out of the distal end.) and the light guide propagates the illumination light in a direction towards the proximal end of the endoscope (The illumination light such as near infrared is propagated towards the proximal end for fluorescence mode. FIGS. 1, 2A-2C). Regarding claim 21, Steiner discloses wherein the non-visible illumination light is emitted from the endoscope is an excitation light (The first light source may have an excitation wavelength in the near infrared. Para [0016]) being used for optical excitation of a fluorophore for the purpose of fluorescence imaging (Fluorescent indicator 102 is back-lit by the excitation light 12a, from, for example, a fiber optic channel, when the user enters the fluorescence imaging mode of the system; Para [0020]). Claim(s) 9 is/are rejected under 35 U.S.C. 103 as being unpatentable over Steiner (US 20200337525) in view of Bruemmer (US 20130094181) and Mizuyoshi (US 20090306478). Regarding claim 9, Steiner does not expressly disclose wherein the converter, upon the conversion of the non-visible illumination light into the visible indication light, is configured to effect conversion from shorter wavelengths to longer wavelengths. Mizuyoshi is directed to illumination device for use in an endoscope (abstract) and teaches wherein the converter, upon the conversion of the non-visible illumination light into the visible indication light, is configured to effect conversion from shorter wavelengths to longer wavelengths (Near ultraviolet light is irradiated; Para [0154]; The second wavelength conversion member which also constitutes the wavelength conversion member 145 made of a down-conversion material which absorbs the laser beam from the near-ultraviolet laser light source 135 and is excited to emit green light. Para [0152]). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Steiner to have conversion from a shorter wavelength to a longer wavelength so that higher energy light such as ultraviolet light could be used for illumination and treatment during surgery. Claim(s) 25 is/are rejected under 35 U.S.C. 103 as being unpatentable over Steiner (US 20200337525) in view of Bruemmer (US 20130094181) and further in view of Yoshida (US 20110237895). Regarding claim 25, Steiner does not expressly disclose wherein a filter layer is arranged on the window, wherein the filter layer does not transmit the non- visible illumination light and allows the visible indication light to pass through, and wherein the converter is arranged such that the non-visible illumination light is incident first on the conversion material of the converter and only afterwards on the filter layer. Yoshida is directed to an image capturing apparatus (abstract) and teaches wherein a filter layer (cut filter 22) is arranged on a window, wherein the filter layer does not transmit the non- visible illumination light and allows the visible indication light to pass through (Infrared light cut filter 83 is formed of a notch interference filter and has a filter characteristic of cutting off near infrared light and transmitting visible light and ICG fluorescence. Para [0145]). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to further modify Steiner to have a filter layer (cut filter 22) with the converter of Steiner to ensure filtering (cutting) of non-visible light through the converter. Response to Arguments Applicant’s arguments submitted on 05/20/2026 have been fully considered and are persuasive. Therefore, the rejection dated 03/26/2026 have been withdrawn. However, upon further consideration, a new rejection has been made in view of amendment. See rejection set forth above. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SHANKAR R GHIMIRE whose telephone number is (571)272-0515. The examiner can normally be reached 8 AM - 5 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anhtuan Nguyen can be reached at 571-272-4963. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SHANKAR RAJ GHIMIRE/Examiner, Art Unit 3795 /ANH TUAN T NGUYEN/Supervisory Patent Examiner, Art Unit 3795 6/6/26
Read full office action

Prosecution Timeline

Show 7 earlier events
Feb 19, 2026
Response Filed
Mar 26, 2026
Final Rejection mailed — §103
May 12, 2026
Interview Requested
May 19, 2026
Examiner Interview Summary
May 19, 2026
Applicant Interview (Telephonic)
May 20, 2026
Request for Continued Examination
May 26, 2026
Response after Non-Final Action
Jun 10, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12667239
Endoscopic Vessel Harvesting With Thermal Management and Augmented Reality Display
2y 3m to grant Granted Jun 30, 2026
Patent 12660984
SURGICAL METHODS USING MULTI-SOURCE IMAGING
4y 8m to grant Granted Jun 23, 2026
Patent 12653379
Endoscopic System With Attached Instruments
2y 6m to grant Granted Jun 16, 2026
Patent 12635862
ENDOSCOPE WITH OPTICAL FILTER ARRANGEMENT AND USE
2y 1m to grant Granted May 26, 2026
Patent 12629013
ARTHROSCOPIC PROBE DEVICE, SYSTEM AND METHOD
3y 2m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
76%
Grant Probability
95%
With Interview (+18.9%)
3y 1m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 284 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month